Publications

HomeStanford - Center for Innovative Study Design  > Publications

Publications

Related Books and Book Chapters

  • Committee on Clinical Trial Guidelines (2006). Guidelines for Pre-clinic and Clinical Trial Evaluations for Chinese Herb Medicine Treatment of Osteoporosis and Osteoporotic Fractures. Beijing, People’s Health Publications, 2006.
  • J. Bartroff, T.L. Lai and M.C. Shih (2013). Sequential Experimentation in Clinical Trials: Design and Analysis. Springer, New York.
  • Y. Lu, J. Fang, L. Tian, H. Jin, eds. (2015). Advanced Medical Statistics World Scientific.
  • J. Chen, J. Heyse and T.L. Lai (2017). Medical Product Safety Evaluation: Biological Models and Statistical Methods. Forthcoming from Chapman & Hall.
  • A.S. Deng, T.L. Lai and K.W. Tsang (2017). Data Science and Decision Analytics Forthcoming from Wiley.
  • Lai T, Lu Y, Tsang KW. Adaptive Designs. Oncology Clinical Trials, 2nd Ed. Kelly WK. and Halabi S. (eds). New York, Springer, 2017 (in press).
  • T.L. Lai, P.W. Lavori and K.W. Tsang (2018). Innovative Study Design and Statistical Analysis in Evidence-Based Medicine. Forthcoming from Chapman & Hall.

Related Papers

(2001) Lai TL. Celebrating the New Millennium: Editors’ Invited Article I. Sequential analysis: Some classical problems and new challenges (with discussion and rejoinder). Statistica Sinica; 11(2):303–351.

(2001) Bloch, DA, Lai TL, Tubert-Bitter P. One-sided tests in clinical trials with multiple endpoints. Biometrics; 57(4):1039–1047.

(2003) Lai TL, Shih MC, Zhu G. Statistics in pharmacology and pre-clinical studies. Advanced Medical Statistics; 409–442.

(2003) Lai TL, Shih MC. Nonparametric estimation in nonlinear mixed effects models. Biometrika; 90(1):1–13.

(2003) Lai TL, Shih MC. A hybrid estimator in nonlinear and generalized linear mixed effects models. Biometrika; 90(4):859–879.

(2003) Lu Y, Jin H, Genant HK. On the equivalence of two diagnostic tests based on paired observations. Statistics in Medicine 2003 Oct; 22(10):3029-44.

(2004) Lai TL, Shih MC. Power, sample size and adaptation considerations in the design of group sequential trials. Biometrika; 91(3):509–528.

(2005) Lu Y, Jin H, Lamborn KR. A design of phase II cancer trials with both total and complete response endpoints. Statistics in Medicine 2005 Oct 30; 24(20):3155-70.

(2006) Lai TL, Shih MC, Zhu G. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials. Stat. Med.; 25(7):1149-67. PMID: 16189814 .

(2006) Lai Tl, Shih MC, Wong SP. A new approach to modeling covariate effects and individualization in population pharmacokinetics-pharmacodynamics. J. Pharmacok. Pharmacodynam. 33(1):49–74. PMID: 16402288 doi: 10.1007/s10928-005-9000-2

(2006) Lai TL, Li Wenzhi. Confidence intervals in group sequential trials with random group sizes and applications to survival analysis. Biometrika 93(3):641–654. doi: 10.1093/biomet/93.3.641

(2007) Bloch DA, Lai TL, Su Z, Tubert-Bitter P. A combined superiority and non-inferiority approach to multiple endpoints in clinical trials. Stat. Med. 26(6):1193–1207. PMID: 16791905 doi: 10.1002/sim.2611

(2008) Bartroff J, Lai TL. Efficient adaptive designs with mid-course sample size adjustment in clinical trials. Stat. Med. 27(10):1593–1611. doi: 10.1002/sim.3201

(2009) Jin H, Lu Y. A non-inferiority test of areas under two parametric ROC curves. Contemp Clin Trials. 2009 Jul; 30(4):375-379. PMID: 19336261 doi:10.1016/j.cct.2009.03.003

(2009) Fan S, Venook AP, Lu Y. Design issues in dose-finding phase I trials for combinations of two agents. Journal of Biopharmaceutical Statistics 2009; 19(3): 509-23. PMID: 19384692.

(2009) Wisniewski, SR, Rush, AJ, Nierenberg, AA, Gaynes, BN, Warden, D, Luther, JF, McGrath, PJ, Lavori, PW, Thase, ME, Fava, M, Trivedi, MH. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am. J. Psychiatry; 166(5):599-607. PMID: 19339358.

(2010) Shih MC, Lai TL, Heyse JF, Chen J. Sequential generalized likelihood ratio tests for vaccine safety evaluation. Stat. Med. 29(26):2698–2708. PMID: 20799244 PMCID: PMC2975406 doi: 10.1002/sim.4036

(2011) Bartroff J, Lai TL. Incorporating individual and collective ethics into Phase I cancer trial designs. Biometrics 67(2):596–603. PMID: 20731643 PMCID: PMC4485382 doi: 10.1111/j.1541-0420.2010.01471.x

(2011) Lai TL, Lavori PW. Innovative clinical trial designs: Toward a 21st-century health care system. Stat. Biosci. 3(2):145–168. PMID: 26140056, PMCID:PMC4485389. doi: 10.1007/s12561-011-9042-5.

(2012) Lai TL, Lavori PW, Shih MC. Adaptive Trial Designs. Annual Review of Pharmacology and Toxicology, Vol. 52, pp 101-110.

(2012) Lai TL, Lavori PW, Shih MC. Sequential design of Phase II-III cancer trials. Stat. Med. 31(18):1944–1960. PMID: 22422502, PMCID:PMC4532356. doi: 10.1002/sim.5346.

(2012) Lai TL, Lavori PW, Shih MC, Sikic BI. Clinical trial designs for testing biomarker-based personalized therapies. Clin. Trials. 9(2): 141–154. doi: 10.1177/1740774512437252. PMID: 22397801, PMCID: PMC4296980.

(2012) Fan S, Lu Y, Wang Y. A Simple Bayesian Decision-Theoretic Design for Dose-Finding Trials. Statistics in Medicine 2012 31(28):3719-3730. PMID: 22763943 doi: 10.1002/sim.5438.

(2012) Lu Y, Fan S. On the Time to Conclusion of Phase II Cancer Clinical Trials and Its Application in Trial Designs. Statistics in Biopharmaceutical Research. 2012; 4(4):324-335.

(2013) Lai TL, Liao OY, Kim DW. Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research. Contemp. Clin. Trials; 36(2):651–663. PMID: 23994669 doi: 10.1016/j.cct.2013.08.007

(2014) Bartroff J, Lai TL, Narasimhan B. A new approach to designing phase I-II cancer trials for cytotoxic chemotherapies. Stat. Med. 33, 2718–2735. PMID: 24577750 PMCID:PMC4048734. doi: 10.1002/sim.6124

(2014) TL Lai, PW Lavori, O Yueh-Wen Liao. Adaptive choice of patient subgroup for comparing two treatments. Contemporary Clinical Trials, Vol. 39(2), 191–200. PMID: 25205644 PMCID: PMC4470707 doi: 10.1016/j.cct.2014.09.001

(2015) Schnurr PP, Chard KM, Ruzek JI, Chow BK, Shih M-C, Resick PA, Foa EB, Marx BP, Huang G. and Lu Y. Design of VA Cooperative Study #591: CERV-PTSD, Comparative Effectiveness Research in Veterans with PTSD. Contemporary Clinical Trials Volume 41, March 2015, Pages 75-84. doi:10.1016/j.cct.2014.11.017

(2015) He P, Lai TL, Su Z. Design of clinical trials with failure-time endpoints and interim analyses: An update after fifteen years. Contemp. Clin. Trials 10th Anniversary Special Issue, 45 (Part A):103–112. PMID: 26031459 doi: 10.1016/j.cct.2015.05.018

(2015) Lai TL, Lavori PW, Tsang KW. Adaptive design of confirmatory trials: Advances and challenges. Contemp. Clin. Trials 10th Anniver- sary Special Issue, 45 (Part A):93–102. PMID: 26079372 PMCID: PMC4639447 doi: 10.1016/j.cct.2015.06.007

(2015) Shih MC, Turakhia M, Lai TL. Innovative designs of point-of-care comparative effectiveness trials. Contemp. Clin. Trials 10th An- niversary Special Issue, 45 (Part A):61–68. PMID: 26099528 PMCID: PMC4639459 doi: 10.1016/j.cct.2015.06.014

(2016) M.G. Lansberg, N.S. Bhat, S.D. Yeatts, Y.Y. Palesch, J.P. Broderick, G.W. Albers, T.L. Lai and P.W. Lavori. Power of an adaptive trial design for endovascular stroke studies: Simulations using IMS (Interventional Management of Stroke) III data. Stroke, 47(12):2931-2937. PMID: 27895297, PMCID: PMC5134921.

(2016) Belitskaya I, Wang H, Shih MC, Tian L, Doros G, Lew RA, and Lu Y. A New Overall-Subgroup Simultaneous Test for Optimal Inference in Biomarker-Targeted Confirmatory Trials. Statistics in Biosciences, DOI: 10.1007/s12561-016-9174-8.

(2017) Lee BL, Fan S, Lu Y. A curve-free Bayesian decision-theoretic design for two-agent phase I trials. Journal of Biopharmaceutical Statistics, 27(1):34-43. PMID: 26882373.

Software

© 2025 Center for Innovative Study Design. All rights reserved.
site by Pendari